Ultragenyx Pharmaceutical Inc. buy Robert W. Baird
Start price
30.12.25
/
50%
€17.00
Target price
30.12.26
€39.91
Performance (%)
39.18%
Price
27.07.26
?
Summary
This prediction is currently active. With a performance of 39.18% the BUY prediction by Robert_W__Baird is a big success. This prediction currently runs until 30.12.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.966% | -7.966% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by Robert_W__Baird for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Robert W. Baird from $72.00 to $47.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.00
31.05.24
31.05.24
€66.15
31.05.25
31.05.25
-17.78%
01.06.25
01.06.25
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.80
30.01.24
30.01.24
€62.74
30.01.25
30.01.25
1.96%
31.01.25
31.01.25